See more : Cookpad Inc. (2193.T) Income Statement Analysis – Financial Results
Complete financial analysis of Atrys Health, S.A. (ATRY.MC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Atrys Health, S.A., a leading company in the Biotechnology industry within the Healthcare sector.
- Bank of Cyprus Holdings Public Limited Company (BOCH.L) Income Statement Analysis – Financial Results
- Intellego Technologies AB (INT.ST) Income Statement Analysis – Financial Results
- Lifezone Metals Limited (LZM) Income Statement Analysis – Financial Results
- Wacom Co., Ltd. (WACMY) Income Statement Analysis – Financial Results
- Owlet, Inc. (OWLT-WT) Income Statement Analysis – Financial Results
Atrys Health, S.A. (ATRY.MC)
About Atrys Health, S.A.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 201.57M | 186.99M | 121.01M | 31.40M | 14.84M | 7.29M | 6.04M | 4.56M | 2.87M | 1.09M | 1.02M | 1.08M |
| Cost of Revenue | 59.80M | 32.48M | 20.12M | 7.15M | 2.64M | 421.78K | 140.89K | 117.07K | 759.40K | 1.00M | 1.95M | 2.01M |
| Gross Profit | 141.77M | 154.51M | 100.89M | 24.25M | 12.20M | 6.87M | 5.89M | 4.44M | 2.11M | 87.46K | -927.06K | -925.81K |
| Gross Profit Ratio | 70.33% | 82.63% | 83.37% | 77.24% | 82.21% | 94.22% | 97.67% | 97.43% | 73.50% | 8.03% | -90.99% | -85.78% |
| Research & Development | 3.12M | 1.67M | 1.94M | 1.26M | 1.63M | 301.17K | 300.80K | 275.73K | 92.24K | 95.12K | 629.30K | 756.71K |
| General & Administrative | 6.09M | 18.00M | 14.15M | 3.08M | 0.00 | 0.00 | 1.83M | 1.75M | 172.04K | 18.52K | 15.96K | 17.17K |
| Selling & Marketing | 785.00K | 788.00K | 678.00K | 213.00K | 0.00 | 0.00 | 0.00 | 0.00 | 8.28K | 6.22K | 6.60K | 13.52K |
| SG&A | 6.87M | 18.79M | 14.83M | 8.36M | 4.17M | 2.36M | 1.83M | 1.75M | 180.33K | 24.74K | 22.56K | 30.69K |
| Other Expenses | 136.74M | 134.37M | 98.46M | 22.46M | 11.01M | 63.91K | -106.01K | -278.27 | -179.35K | 1.00 | 1.00 | 0.00 |
| Operating Expenses | 143.61M | 154.83M | 113.29M | 22.46M | 11.01M | 6.17M | 5.37M | 4.54M | 536.49K | -534.93K | -1.65M | -1.78M |
| Cost & Expenses | 203.41M | 187.31M | 133.41M | 29.60M | 13.65M | 6.59M | 5.51M | 4.66M | 2.65M | 636.64K | 1.14M | 999.69K |
| Interest Income | 627.00K | 304.00K | 1.85M | 209.60K | 655.10 | 254.92 | 165.09 | 79.83K | 495.46K | 358.13K | 8.19K | 0.00 |
| Interest Expense | 33.05M | 4.01M | 11.03M | 2.26M | 1.06M | 609.44K | 1.01M | 685.98K | 527.03K | 0.00 | 352.62K | 304.00K |
| Depreciation & Amortization | 29.67M | 25.97M | 20.79M | 3.82M | 1.91M | 1.28M | 1.11M | 1.18M | 322.09K | 209.92K | 309.21K | 407.48K |
| EBITDA | 31.91M | 16.63M | 5.87M | 4.81M | 3.17M | 1.96M | 1.66M | 1.74M | 1.88M | 661.34K | 186.71K | 526.35K |
| EBITDA Ratio | 15.83% | 20.70% | 6.98% | 15.31% | 20.68% | 27.88% | 28.36% | 25.28% | 64.97% | 60.70% | 19.23% | 48.77% |
| Operating Income | -1.58M | 8.37M | -12.34M | 983.03K | 1.21M | 769.96K | 421.26K | 475.03K | 213.59K | 452.98K | -121.17K | 79.59K |
| Operating Income Ratio | -0.78% | 4.48% | -10.20% | 3.13% | 8.19% | 10.56% | 6.98% | 10.42% | 7.45% | 41.57% | -11.89% | 7.37% |
| Total Other Income/Expenses | -32.11M | -16.04M | -9.87M | -5.15M | -723.76K | -770.61K | -887.50K | 350.61K | 787.00K | -353.29K | -355.32K | -306.13K |
| Income Before Tax | -33.70M | -24.69M | -24.88M | -1.31M | 206.65K | 63.64K | -648.41K | -144.68K | 1.00M | 97.36K | -476.49K | -226.54K |
| Income Before Tax Ratio | -16.72% | -13.21% | -20.56% | -4.17% | 1.39% | 0.87% | -10.74% | -3.17% | 34.91% | 8.94% | -46.76% | -20.99% |
| Income Tax Expense | -2.94M | -1.23M | -1.69M | 706.61K | 311.43K | 51.65K | -745.56K | -207.72K | -294.20K | -222.84K | -813.02K | -908.35K |
| Net Income | -45.59M | -23.47M | -23.20M | -2.02M | -104.79K | 11.99K | 97.16K | 63.04K | 1.29M | 320.20K | 336.53K | 681.81K |
| Net Income Ratio | -22.62% | -12.55% | -19.17% | -6.42% | -0.71% | 0.16% | 1.61% | 1.38% | 45.18% | 29.39% | 33.03% | 63.17% |
| EPS | -0.60 | -0.34 | -0.43 | -0.07 | 0.00 | 0.00 | 0.03 | 0.01 | 0.16 | 0.04 | 0.04 | 0.08 |
| EPS Diluted | -0.60 | -0.34 | -0.43 | -0.07 | 0.00 | 0.00 | 0.03 | 0.01 | 0.16 | 0.04 | 0.04 | 0.08 |
| Weighted Avg Shares Out | 75.81M | 68.20M | 53.52M | 28.32M | 21.46M | 19.46M | 10.86M | 10.51M | 8.11M | 8.11M | 8.11M | 8.11M |
| Weighted Avg Shares Out (Dil) | 75.81M | 68.20M | 53.52M | 28.32M | 21.46M | 19.46M | 10.86M | 10.87M | 8.11M | 8.11M | 8.11M | 8.11M |
Source: https://incomestatements.info
Category: Stock Reports